Search This Blog

Wednesday, August 7, 2019

Horizon Pharma EPS beats by $0.12, beats on revenue

Horizon Pharma (NASDAQ:HZNP): Q2 Non-GAAP EPS of $0.49 beats by $0.12; GAAP EPS of -$0.03.
Revenue of $320.6M (+5.9% Y/Y) beats by $24.33M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)